Haemonetics (NYSE:HAE) reported its Q4 earnings results on Thursday, May 11, 2023 at 06:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Haemonetics beat estimated earnings by 10.0%, reporting an EPS of $0.77 versus an estimate of $0.7.
Revenue was up $39.41 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 0.5% increase in the share price the next day.
Here’s a look at Haemonetics’s past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.80 | 0.67 | 0.51 | 0.60 |
| EPS Actual | 0.85 | 0.83 | 0.58 | 0.65 |
| Revenue Estimate | 300.47M | 269.22M | 249.00M | 257.82M |
| Revenue Actual | 305.30M | 297.49M | 261.46M | 265.00M |
To track all earnings releases for Haemonetics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
